Market data loadingS&P 500--NASDAQ--Data as of latest ETNo timestamp

AvePoint, Inc. (AVPT) Guidance & Earnings Results

On 2026-08-06 AvePoint, Inc. raised guidance: "Full-year ARR guidance raised to $522.1M-$528.1M (26% YoY growth midpoint); Q3 revenue…" — from its own filing, as read by EquiReason.

Source: SEC EDGAR filings · figures as of 2026-06-30 · read by EquiReason

AVPTAvePoint, Inc.Follow AVPT — free
Software - Infrastructure · Technology
—
Price chart with a free account
Market cap
3.5B
P/E TTM
51.6
Dividend yield
—
52-week
—
Next earnings
5 Nov, in 12 days

What management guided

each earnings 8-K · figures checked against the filing text
ReleaseDirectionWhat they said
6 Aug 26RaisedFull-year ARR guidance raised to $522.1M-$528.1M (26% YoY growth midpoint); Q3 revenue $128.2M-$130.2M · full year
7 May 26RaisedFull-year ARR guidance raised to $523.4M-$529.4M (26% YoY growth); revenue guidance $509.4M-$515.4M (22% YoY growth); non-GAAP operating income $91.5M-$94.5M · full year
26 Feb 26Raised2026 ARR growth acceleration relative to 2025 (ex-Ydentic) · full year
6 Nov 25RaisedFY2025 total revenue raised to $414.8M-$416.8M (from prior); non-GAAP operating income raised to $77.3M-$78.3M · full year
7 Aug 25RaisedFY25 total revenue raised to $406.6-410.6M from prior guidance (not explicitly stated but implied by 'raising full-year guidance for all metrics'); FY25 ARR raised to $412.8-418.8M; FY25 non-GAAP operating income raised to $68.3-70.8M; Q3 2025 total revenue $104.6-106.6M; Q3 2025 non-GAAP operating income $18.0-19.0M · full year

AvePoint, Inc. — questions

What guidance did AvePoint, Inc. give?
On 2026-08-06: "Full-year ARR guidance raised to $522.1M-$528.1M (26% YoY growth midpoint); Q3 revenue $128.2M-$130.2M"
When does AvePoint, Inc. report earnings?
AvePoint, Inc.'s next earnings report is expected on 2026-11-05.

Every figure on this page comes from AvePoint, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.

How these figures are read: methodology · EquiReason.